Therefore, miR-671-5p suppressed the progression of ESCC by suppressing the expression of FGFR2 via inhibiting the MAPK-ERK and PI3K-AKT pathways. This evidence concerns the gene FGFR2 and esophageal squamous cell carcinoma.